Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer

We retrospectively evaluated if personalized Kampo medicine (PKM) could facilitate CTL responses and clinical benefits induced by personalized peptide vaccination (PPV), in which HLA-matched vaccines were selected and administered based on the preexisting host immunity, for advanced esophageal cance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Evid Based Complement Alternat Med
Main Authors: Muroya, Daisuke, Yutani, Shigeru, Shichijo, Shigeki, Yamada, Akira, Sakamoto, Shinjiro, Naito, Masayasu, Okuda, Koji, Morita, Michi, Yamaguchi, Rin, Itoh, Kyogo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040795/
https://ncbi.nlm.nih.gov/pubmed/27703488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5929525
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados